LAS VEGAS, Feb. 13, 2024 /PRNewswire/ — Heligenics, Inc., introduces a groundbreaking advancement in the discovery of new medicines. This cutting-edge research marks a pivotal moment in the field of biopharmaceuticals, in which High Content Screening, historically used for screening…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.